Table 2.

Clinical trials using hUMSCs for treatment (clinicaltrials.gov)

Study number	Phase/status	Name of study	Intervention	Design of study
NCT01219465	1and 2; ongoing	Safety and efficacy of umbilical cord mesenchymal stem cells infusion for Initial Type 1 diabetes	Umbilical cord mesenchymal stem cells	Allocation: Non-Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment
NCT01221428	1and 2; ongoing	Safety and efficacy of umbilical cord mesenchymal stem cells infusion for ulcerative colitis	Umbilical cord mesenchymal stem cells i.v infusion	Allocation: Non-Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment
NCT01342250	Completed	Study of human umbilical cord mesenchymal stem cells transplantation for Patients with decompensated liver cirrhosis	Conventional therapy plus low dose hUMSC treatment	Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment